Plus Therapeutics Inc Earnings

The next earnings date for Plus Therapeutics Inc has not yet been scheduled.

Analyst Estimates of Plus Therapeutics Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Plus Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/12/2025Before Market------
05/13/2025Before Market------
03/03/2025Before Market------
11/04/2024After Market$-0.3733.93%
08/12/2024Before Market$-0.56-5.66%
05/15/2024After Market$-0.7531.19%
03/05/2024After Market$-0.8421.50%
10/31/2023After Market$-110.71%
08/14/2023After Market$-0.5969.11%
04/20/2023After Market$-0.14-7.69%
02/23/2023After Market$-0.22-83.33%
10/20/2022After Market$-0.195.00%
07/21/2022After Market$-0.24-9.09%
04/21/2022After Market$-0.19-5.56%
02/24/2022After Market$-0.270.00%
10/21/2021After Market$-0.28-16.67%
07/22/2021After Market$-0.25-4.17%
04/22/2021After Market$-0.332.94%
02/22/2021After Market$-0.67-71.79%
10/22/2020After Market$-0.3929.09%
08/10/2020Before Market$-0.2665.33%
05/14/2020After Market$-0.2862.67%
03/30/2020After Market$0.23134.85%
11/14/2019After Market$-0.0399.49%
08/15/2019After Market$-5.1247.49%
05/14/2019After Market$-910.00%
03/29/2019Before Market$-8.0545.13%
11/14/2018After Market$-21-42.37%
08/14/2018After Market$-29.50-18.00%
05/10/2018After Market$-35-12.00%
03/08/2018After Market$-50-17.65%
11/09/2017After Market$-709.68%
08/10/2017After Market$-959.52%
05/11/2017After Market$-1307.14%
03/23/2017After Market$-120-4.35%
11/09/2016After Market$-130-8.33%
08/04/2016After Market$-215-10.26%
05/10/2016After Market$-202.5019.00%
03/03/2016After Market$-22525.00%
11/05/2015After Market$-30027.27%
08/06/2015After Market$-450-125.00%
05/11/2015After Market$-525-3.70%
03/12/2015After Market$-6000.00%
11/06/2014After Market$-900-71.43%
08/11/2014---$-1,125-19.05%
05/12/2014---$-1,050-1.82%
03/12/2014---$-1,050-20.69%
11/07/2013---$-1,050-27.27%
08/08/2013---$-37560.78%
05/09/2013---$-82526.67%
03/07/2013---$-45061.29%
11/08/2012---$-1,425-23.91%
08/08/2012---$-9757.14%
05/09/2012---$-1,2000.00%
03/08/2012---$-90014.29%
11/03/2011---$-1,1252.17%
08/09/2011---$-75034.78%
05/05/2011---$-1,725-46.03%
03/10/2011---$-1,350-7.46%
11/04/2010---$-1,725-49.74%
08/07/2010---$-900-4.35%
05/06/2010---$-45061.29%
03/12/2010---$-1,800-51.32%
11/09/2009---$-1,350-17.80%
08/10/2009---$-15086.84%
05/11/2009---$-1,500-9.09%
03/06/2009---$-1,65018.52%
11/10/2008---$-1,8009.09%
08/08/2008---$-2,475-10.74%
05/09/2008---$-2,5506.08%
03/12/2008---$-3,300-25.12%
11/12/2007---$-1,65038.89%
08/14/2007---$-1,27557.50%
05/11/2007---$-48,608.18---
03/30/2007---$-75067.74%
11/15/2006---$-59,267.01---
08/14/2006---$-52,764.04---
05/15/2006---$-54,368.78---
03/30/2006---$-107,999.99---
11/14/2005---$-16,959.85---
08/15/2005---$-41,925.85---
05/12/2005---$-36,496.69---
11/02/2004---$34,882.64---
08/16/2004---$-30,791.61---
05/12/2004---$11,376.39---
03/30/2004---$-8,850.02---
11/03/2003---$-21,559.85---

More About Plus Therapeutics Inc

Website
https://plustherapeutics.com
Country
USA
Full Time Employees
21

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is REYOBIQ, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary liver cancers by intra-arterial injection. In addition, it develops and commercializes laboratory-developed tests, such as the CNSide Test to identify tumor cells that have metastasized to the central nervous system in patients with carcinomas and melanomas. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Houston, Texas.

“Plus Therapeutics Inc Earnings” Can Refer to the Plus Therapeutics Inc Earnings Date

Some people say “Plus Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Plus Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Plus Therapeutics Inc Stock on the Earnings Date

If you own Plus Therapeutics Inc stock (PSTV) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Plus Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Plus Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Plus Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Plus Therapeutics Inc earnings or anything else related to the stock market.